Integrated Diagnostics (LON:IDHC) Stock Price Down 11.9% – What’s Next?

Shares of Integrated Diagnostics Holdings plc (LON:IDHC) were down 11.9% during mid-day trading on Tuesday . The stock traded as low as GBX 0.49 and last traded at GBX 0.50. 953,582 shares were traded during mid-day trading, an increase of 436% from the average daily volume of 177,907 shares. The stock had previously closed at GBX 0.56.

Integrated Diagnostics Price Performance

The business has a 50-day simple moving average of GBX 0.58 and a two-hundred day simple moving average of GBX 0.62. The company has a debt-to-equity ratio of 43.40, a quick ratio of 0.75 and a current ratio of 1.53. The company has a market capitalization of £2.91 million, a price-to-earnings ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.38.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.